NFKB1 and cervical carcinoma: Ursolic acid from Ligustrum lucidum and the chemotherapeutic drug cisplatin, have been shown to inhibit cervical cancer cell growth through interfering with NF-κB signaling pathway via decreasing p65 level (Li et al., 2017a).